References
- Kumar, S. A.; Sanjita, D. A. Review Article on Bioavailability and Bioequivalence Studies. Int. J. Pharmtech. Res. 2013, 5, 1711–1721.
- Mateus, A.; Gordon, L. J.; Wayne, G. J.; Almqvist, H.; Axelsson, H.; Seashore-Ludlow, B.; Treyer, A.; Matsson, P.; Lundback, T.; West, A.; et al. Prediction of Intracellular Exposure Bridges the Gap between Target- and Cell-Based Drug Discovery. Proc. Natl. Acad. Sci. USA. 2017, 114, E6231–E6239. DOI: https://doi.org/10.1073/pnas.1701848114.
- Alavijeh, M.; S; Chishty, M.; Qaiser, M. Z.; Palmer, A. Z. Drug Metabolism and Pharmacokinetics, the Blood-Brain Barrier, and Central Nervous System Drug Discovery. NeuroRx. 2005, 2, 554–571. DOI: https://doi.org/10.1602/neurorx.2.4.554.
- Dollery, C. T. Intracellular Drug Concentrations. Clin. Pharmacol. Ther. 2013, 93, 263–266. DOI: https://doi.org/10.1038/clpt.2012.240.
- Leucuta, S. E. Subcellular Drug Targeting, Pharmacokinetics and Bioavailability. J. Drug Target. 2014, 22, 95–115. DOI: https://doi.org/10.3109/1061186X.2013.848453.
- Shariatgorji, M.; Nilsson, A.; Fridjonsdottir, E.; Vallianatou, T.; Kallback, P.; Katan, L.; Savmarker, J.; Mantas, L.; Zhang, X.; Bezard, E.; et al. Comprehensive Mapping of Neurotransmitter Networks by MALDI–MS Imaging. Nat. Methods. 2019, 16, 1021–1028. DOI: https://doi.org/10.1038/s41592-019-0551-3.
- Losilevsky, G.; Israel, O.; Frenkel, A.; Even-Sapir, E.; Ben-Haim, S.; Front, A.; Kolodny, G. M.; Front, D. Practical SPECT Technique for Quantitation of Drug Delivery to Human Tumors and Organ Absorbed Radiation Dose. Semin. Nucl. Med. 1989, 19, 33–46. DOI: https://doi.org/10.1016/S0001-2998(89)80034-0.
- Moriguchi, S.; Kimura, Y.; Ichise, M.; Arakawa, R.; Takano, H.; Seki, C.; Ikoma, Y.; Takahata, K.; Nagashima, T.; Yamada, M.; et al. PET Quantification of the Norepinephrine Transporter in Human Brain with (S,S)-18F-FMeNER-D2. J. Nucl. Med. 2017, 58, 1140–1145. DOI: https://doi.org/10.2967/jnumed.116.178913.
- Federau, C.; Maeder, P.; Brien, K.; O; Browaeys, P.; Meuli, R.; Hagmann, P. Quantitative Measurement of Brain Perfusion with Intravoxel Incoherent Motion MR Imaging. Radiology 2012, 265, 874–881. DOI: https://doi.org/10.1148/radiol.12120584.
- Vismeh, R.; Waldon, D. J.; Teffera, Y.; Zhao, Z. Localization and Quantification of Drugs in Animal Tissues by Use of Desorption Electrospray Ionization Mass Spectrometry Imaging. Anal. Chem. 2012, 84, 5439–5445. DOI: https://doi.org/10.1021/ac3011654.
- Solon, E. G. Autoradiography Techniques and Quantification of Drug Distribution. Cell Tissue Res. 2015, 360, 87–107. DOI: https://doi.org/10.1007/s00441-014-2093-4.
- Kuhnline Sloan, C. D.; Nandi, P.; Linz, T. H.; Aldrich, J.; V; Audus, K. L.; Lunte, S. M. Analytical and Biological Methods for Probing the Blood-Brain Barrier. Annu. Rev. Anal. Chem. 2012, 5, 505–531. DOI: https://doi.org/10.1146/annurev-anchem-062011-143002.
- Al-Majdoub, Z. M.; Al Feteisi, H.; Achour, B.; Warwood, S.; Neuhoff, S.; Rostami-Hodjegan, A.; Barber, J. Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients. Mol. Pharm. 2019, 16, 1220–1233. DOI: https://doi.org/10.1021/acs.molpharmaceut.8b01189.
- Reiter, B.; Stimpfl, T. Quantification of Drugs in Brain Samples. J. Anal. Toxicol. 2015, 39, 702–706. DOI: https://doi.org/https://doi-org.eres.qnl.qa/10.1093/jat/bkv078.
- Gilfillan, R.; Glenn, K.; Grant, W. Glycine Transporters and Their Inhibitors. J. Pharmacol. 2009, 4, 223–247. DOI: https://doi.org/10.1007/7355_2009_030.
- Lavrikova, P.; Fontana, J. Cerebrospinal Fluid, Blood-Brain Barrier and Blood-CSF Barrier. In Functions of Cell and Human body. Chap. 11. http://fblt.cz/en/skripta/regulacni-mechanismy-2-nervova-regulace/12-likvor-hematoencefalicka-a-hematolikvorova-bariera/.
- Graff, C. L.; Pollack, G. M. Drug Transport at the Blood-Brain Barrier and the Choroid Plexus. Curr. Drug Metab. 2004, 5, 95–108. DOI: https://doi.org/10.2174/1389200043489126.
- Jones, A. R.; Shusta, E. V. Blood-Brain Barrier Transport of Therapeutics via Receptor-Mediation. Pharm. Res. 2007, 24, 1759–1771. DOI: https://doi.org/10.1007/s11095-007-9379-0.
- Upadhyay, R. K. Drug Delivery Systems, CNS Protection, and the Blood Brain Barrier. Biomed. Res. Int. 2014, 2014, 869269–869237. DOI: https://doi.org/10.1155/2014/869269.
- May, T. W.; Brandt, C.; Helmer, R.; Bien, C. G.; Cawello, W. Comparison of Lacosamide Concentrations in Cerebrospinal Fluid and Serum in Patients with Epilepsy. Epilepsia 2015, 56, 1134–1140. DOI: https://doi.org/10.1111/epi.13022.
- Kondawar, M.; S; Shinde, S. R. Development and Validation of Bioanalytical Method for Lacosamide from Rat Brain Tissues. Int. J. Pharm. Tech. Res. 2012, 4, 1417–1421.
- Dahyot-Fizelier, C.; Frasca, D.; Gregoire, N.; Adier, C.; Mimoz, O.; Debaene, B.; Couet, W.; Marchand, S. Microdialysis Study of Cefotaxime Cerebral Distribution in Patients with Acute Brain Injury. Antimicrob. Agents Chemother. 2013, 57, 2738–2742. DOI: https://doi.org/10.1128/AAC.02570-12.
- Miękus, N.; Konieczna, L.; Kowiański, P.; Moryś, J.; Bączek, T. HILIC-MS Rat Brain Analysis, A New Approach for the Study of Ischemic Attack. Transl Neurosci. 2017, 8, 70–75. DOI: https://doi.org/10.1515/tnsci-2017-0012.
- Fonseca, B. M.; Rodrigues, M.; Alves, G. First HPLC Method for the Simultaneous Quantification of Levetiracetam, Zonisamide, Lamotrigine, Pentylenetetrazole and Pilocarpine in Rat Plasma and Brain. Anal. Methods 2018, 10, 515–525. DOI: https://doi.org/10.1039/C7AY02602A.
- Veech, R. L.; Harris, R. L.; Veloso, D.; Veech, E. H. Freeze-Blowing: A New Technique for the Study of Brain In Vivo. J. Neurochem. 1973, 20, 183–188. DOI: https://doi.org/10.1111/j.1471-4159.1973.tb12115.x.
- Dedrick, D. F.; Sherer, Y. D.; Biebuyck, J. F. Use of a Rapid Brain-Sampling Technique in a Physiologic Preparation: effects of Morphine, Ketamine, and Halothane on Tissue Energy Intermediates. Anesthesiology 1975, 42, 651–657. DOI: https://doi.org/10.1097/00000542-197506000-00002.
- Oberoi, R. K.; Mittapalli, R. K.; Fisher, J.; Elmquist, W. F. Sunitinib LC-MS/MS Assay in Mouse Plasma and Brain Tissue: Application in CNS Distribution Studies. Chromatographia 2013, 76, 1657–1665. no. 23–24, DOI: https://doi.org/10.1007/s10337-013-2528-1.
- Sparidans, R. W.; Wang, Y.; Schinkel, A. H.; Schellens, J. H. M.; Beijnen, J. H. Quantitative Bioanalytical Assay for the Tropomyosin Receptor Kinase Inhibitor Larotrectinib in Mouse Plasma and Tissue Homogenates Using Liquid Chromatography-Tandem Mass Spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2018, 1102-1103, 167–172. DOI: https://doi.org/10.1016/j.jchromb.2018.10.023.
- Ganti, V.; Walker, E. A.; Nagar, S. Pharmacokinetic Application of a Bio-Analytical LC-MS Method Developed for 5-Fluorouracil and Methotrexate in Mouse Plasma, Brain and Urine. Biomed. Chromatogr. 2013, 27, 994–1002. DOI: https://doi.org/10.1002/bmc.2893.
- Respaud, R.; Grayo, S.; Singlas, E.; Dubouch, S.; Le Monnier, A.; Lott, M. C. High-Performance Liquid Chromatography Assay for Moxifloxacin in Brain Tissue and Plasma: Validation in a Pharmacokinetic Study in a Murine Model of Cerebral Listeriosis. J. Anal. Methods Chem. 2012, 2012, 1–1. DOI: https://doi.org/10.1155/2012/436349.
- Łabuzek, K.; Suchy, D.; Gabryel, B.; Bielecka, A.; Liber, S.; Okopień, B. Quantification of Metformin by the HPLC Method in Brain Regions, Cerebrospinal Fluid and Plasma of Rats Treated with Lipopolysaccharide. Pharmacol. Rep. 2010, 62, 956–965. DOI: https://doi.org/10.1016/S1734-1140(10)70357-1.
- Preskorn, S. H.; Glotzbach, R. K.; City, K. A Liquid Chromatographic Method for Quantitating Amitriptyline in Brain Tissue. Psychopharmacology 1982, 78, 25–27. DOI: https://doi.org/10.1007/bf00470581.
- Wong, Y. C.; Wo, S. K.; Zuo, Z. Investigation of the Disposition of Loxapine, Amoxapine and Their Hydroxylated Metabolites in Different Brain Regions, CSF and Plasma of Rat by LC–MS/MS. J. Pharm. Biomed. Anal. 2012, 58, 83–93. DOI: https://doi.org/10.1016/j.jpba.2011.09.020.
- Szegi, P.; Kalász, H.; Laufer, R.; Kuca, K.; Tekes, K. Pyridinium Aldoxime Analysis by HPLC : The Method for Studies on Pharmacokinetics and Stability. Anal. Bioanal. Chem. 2010, 397, 579–586. DOI: https://doi.org/10.1007/s00216-010-3635-6.
- MeirinhoSara, A. Bioanalytical Method Validation of Venlafaxine and Desvenlafaxine in Mouse Plasma, Brain and Liver Using a MEPS/HPLC Assay: A Path to Study These Drugs’ Intranasal Administration. 2015, 37–117. http://hdl.handle.net/10400.6/6438.
- Dalvi, A. V.; Uppuluri, C. T.; Prasanthi, E. B.; Ravi, P. R. Design of Experiments-Based RP–HPLC Bioanalytical Method Development for Estimation of Rufinamide in Rat Plasma and Brain and its Application in Pharmacokinetic Study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2018, 1102-1103, 74–82. DOI: https://doi.org/10.1016/j.jchromb.2018.10.014.
- Bank, W. A. Characteristics of Compounds That Cross the Blood-Brain Barrier. BMC Neurol. 2009, 9(Suppl 1). DOI: https://doi.org/10.1186/1471-2377-9-S1-S3.
- Takasato, Y.; Rapoport, S. I.; Smith, Q. R. An in Situ Brain Perfusion Technique to Study Cerebrovascular Transport in the Rat. Am. J. Physiol. Hear. Circ. Physiol. 1984, 16, 484–493. DOI: https://doi.org/10.1152/ajpheart.1984.247.3.H484.
- Bhattacharjee, A. K.; Nagashima, T.; Kondoh, T.; Tamaki, N. Quantification of Early Blood–Brain Barrier Disruption by in Situ Brain Perfusion Technique. Brain Res. Protoc. 2001, 8, 126–131. DOI: https://doi.org/10.1016/S1385-299X(01)00094-0.
- De Lange, E. C. M.; De Boer, A. G.; Breimer, D. D. Methodological Issues in Microdialysis Sampling for Pharmacokinetic Studies. Adv. Drug Deliv. Rev. 2000, 45, 125–148. DOI: https://doi.org/10.1016/S0169-409X(00)00107-1.
- Erdo, F.; Gordon, J.; Wu, J. T.; Sziráki, I. Verification of Brain Penetration of the Unbound Fraction of a Novel HER2/EGFR Dual Kinase Inhibitor (TAK-285) by Microdialysis in Rats. Brain Res. Bull. 2012, 87, 413–419. DOI: https://doi.org/10.1016/j.brainresbull.2012.01.002.
- Wei, J. B.; Lai, Q.; Shumyak, S. P.; Xu, L. F.; Zhang, C. X.; Ling, J. J.; Yu, Y. An LC/MS Quantitative and Microdialysis Method for Cyclovirobuxine D Pharmacokinetics in Rat Plasma and Brain: The Pharmacokinetic Comparison of Three Different Drug Delivery Routes. J. Chromatogr. Bioanal. Tech. 2015, 1002, 185–193. DOI: https://doi.org/10.1016/j.jchromb.2015.08.022.
- Feng, M.; R; Turluck, D.; Burleigh, J.; Lister, R.; Fan, C.; Middlebrook, A.; Taylor, C.; Su, T. Brain Microdialysis and PK/PD Correlation of Pregabalin in Rats. Eur. J. Drug Metab. Pharmacokinet. 2001, 26, 123–128. DOI: https://doi.org/10.1007/BF03190385.
- Nirogi, R.; Mudigonda, K.; Kandikere, V.; Ponnamaneni, R. Quantification of Acetylcholine, an Essential Neurotransmitter, in Brain Microdialysis Samples by Liquid Chromatography Mass Spectrometry. Biomed. Chromatogr. 2010, 24, 39–48. DOI: https://doi.org/10.1002/bmc.1347.
- Bergadano, A.; Amen, E. M.; Jacobsen, B.; Belli, S.; Vandjour, A.; Rapp, C.; Senn, C. A Minimally-Invasive Serial Cerebrospinal Fluid Sampling Model in Conscious Göttingen Minipigs. J. Biol. Met. 2019, 6, 107. DOI: https://doi.org/10.14440/jbm.2019.265.
- Holder, B. R.; Mcnaney, C. A.; Luchetti, D.; Schaeffer, E.; Drexler, D. M. Bioanalysis of Acetylcarnitine in Cerebrospinal Fluid by HILIC-Mass Spectrometry. Biomed. Chromatogr. 2015, 29, 1375–1379. DOI: https://doi.org/10.1002/bmc.3433.
- Yilmaz, A.; Watson, V.; Dickinson, L.; Back, D. Efavirenz Pharmacokinetics in Cerebrospinal Fluid and Plasma over a 24-Hour Dosing Interval. Antimicrob. Agents Chemother. 2012, 56, 4583–4585. DOI: https://doi.org/10.1128/AAC.06311-11.
- Jiang, J.; James, C. A.; Wong, P. Bioanalytical Method Development and Validation for the Determination of Glycine in Human Cerebrospinal Fluid by Ion-Pair Reversed-Phase Liquid Chromatography-Tandem Mass Spectrometry. J. Pharm. Biomed. Anal. 2016, 128, 132–140. DOI: https://doi.org/10.1016/j.jpba.2016.05.019.
- Van Toi, P.; Pouplin, T.; Tho, N. D. K.; Phuong, P. N.; Chau, T. T. H.; Thuong Thuong, N. T.; Heemskerk, D.; Hien, T. T.; Thwaites, G. E. High-Performance Liquid Chromatography with Time-Programmed Fluorescence Detection for the Quantification of Levofloxacin in Human Plasma and Cerebrospinal Fluid in Adults with Tuberculous Meningitis. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2017, 1061–1062, 256–262. DOI: https://doi.org/10.1016/j.jchromb.2017.07.032.
- Petrocheilou, M.; Samanidou, V.; Kovatsi, L.; Tsolaki, M.; Papadoyannis, I. A Simple and Direct HPLC-DAD Method for the Simultaneous Determination of Galantamine, Donepezil and Rivastigmine in Cerebrospinal Fluid, Blood Serum and Urine. J. Appl. Bioanal. 2017, 3, 59–69. DOI: https://doi.org/10.17145/jab.17.010.
- Heetla, H. W.; Proost, J. H.; Molmans, B. H.; Staal, M. J.; Van Laar, T. A Pharmacokinetic-Pharmacodynamic Model for Intrathecal Baclofen in Patients with Severe Spasticity. Br. J. Clin. Pharmacol. 2016, 81, 101–112. DOI: https://doi.org/10.1111/bcp.12781.
- Sakurada, O.; Kennedy, C.; Jehle, J.; Brown, J.; D; Carbin, G. L.; Sokoloff, L. Measurement of Local Cerebral Blood Flow with Iodo [14C] Antipyrine. Am. J. Physiol. 1978, 234, 59–66. DOI: https://doi.org/10.1152/ajpheart.1978.234.1.H59.
- Sokoloff, L.; Reivich, M.; Kennedy, C.; Rosiers, M. H. D.; Patlak, C. S.; Pettigrew, K. D.; Sakurada, O.; Shinohara, M. The [14C]Deoxyglucose Method for the Measurement of Local Cerebral Glucose Utilization: Theory, Procedure, and Normal Values in the Conscious and Anesthetized Albino Rat. J. Neurochem. 1977, 28, 897–916. DOI: https://doi.org/10.1111/j.1471-4159.1977.tb10649.x.
- Dwyer, B. E.; Donatoni, P.; Wasterlain, C. G. A Quantitative Autoradiographic Method for the Measurement of Local Rates of Brain Protein Synthesis. Neurochem. Res. 1982, 7, 563–576. DOI: 0364-3190/82/0500-0563503.00/0. DOI: https://doi.org/10.1007/BF00965123.
- Wu, C. H.; Yang, B. H.; Chou, Y. H.; Wang, S. J.; Chen, J. C. Effects of 99mTc-TRODAT-1 Drug Template on Image Quantitative Analysis. PLoS One. 2018, 13, e0194503. pone.0194503. DOI: https://doi.org/10.1371/journal.
- Newman, S. P.; Hirst, P. H.; Wilding, I. R. Imaging Techniques for Assessing Drug Delivery in Man. Eur. J. Pharm. Sci. 2003, 18, 19–189. DOI: https://doi.org/10.1016/S1461-5347(99)00152-2.
- Bickel, U. How to Measure Drug Transport across the Blood-Brain Barrier. NeuroRx 2005, 2, 15–26. DOI: https://doi.org/10.1602/neurorx.2.1.15.
- Keller, C.; Maeda, J.; Jayaraman, D.; Chakraborty, S.; Sussman, M. R.; Harris, J. M.; Ané, J. M.; Li, L. Comparison of Vacuum MALDI and AP-MALDI Platforms for the Mass Spectrometry Imaging of Metabolites Involved in Salt Stress in Medicago truncatula. Front. Plant Sci. 2018, 9, 1238–1215. DOI: https://doi.org/10.3389/fpls.2018.01238.
- Wu, C.; Dill, A. L.; Eberlin, L. S.; Cooks, R. G.; Ifa, D. R. Mass Spectrometry Imaging under Ambient Conditions. Mass Spectrom. Rev. 2013, 32, 218–243. DOI: https://doi.org/10.1002/mas.21360.
- Parrot, D.; Papazian, S.; Foil, D.; Tasdemir, D. Imaging the Unimaginable: Desorption Electrospray Ionization – Imaging Mass Spectrometry (DESI-IMS) in Natural Product Research. Planta Med. 2018, 84, 584–593. DOI: https://doi.org/10.1055/s-0044-100188.
- Heymans, M.; Sevin, E.; Gosselet, F.; Lundquist, S.; Culot, M. Mimicking Brain Tissue Binding in an In Vitro Model of the Blood-Brain Barrier Illustrates Differences between In Vitro and In Vivo Methods for Assessing the Rate of Brain Penetration. Eur. J. Pharm. Biopharm. 2018, 127, 453–461. DOI: https://doi.org/10.1016/j.ejpb.2018.03.007.
- Hartz, A. M. S.; Schulz, J. A.; Sokola, B.; S; Edelmann, S. E.; Shen, A.; N; Rempe, R. G.; Zhong, Y.; Seblani, N. E.; Bauer, B. Isolation of Cerebral Capillaries from Fresh Human Brain Tissue. J. Vis. Exp. 2018, 139, 1–12. DOI: https://doi.org/10.3791/57346.
- Audus, K. L.; Borchardt, R. T. Characterization of an In Vitro Blood-Brain Barrier Model System for Studying Drug Transport and Metabolism. Pharm. Res. 1986, 3, 81–87. DOI: https://doi.org/10.1023/A:1016337202335.
- Betz, A. L.; Firth, J. A.; Goldstein, G. W. Polarity of the Blood-Brain Barrier: Distribution of Enzymes between the Luminal and Antiluminal Membranes of Brain Capillary Endothelial Cells. Brain Res. 1980, 192, 17–28. DOI: https://doi.org/10.1016/0006-8993(80)91004-5.
- Lundquist, S.; Renftel, M. The Use of in Vitro Cell Culture Models for Mechanistic Studies and as Permeability Screens for the Blood–Brain Barrier in the Pharmaceutical Industry—Background and Current Status in the Drug Discovery Process. Vascul. Pharmacol. 2002, 38, 355–364. DOI: https://doi.org/10.1016/S1537-1891(02)00203-3.
- Bors, L. A.; Erd, F. Overcoming the Blood–Brain Barrier. Challenges and Tricks for CNS Drug Delivery. Sci. Pharm. 2019, 87, 6. DOI: https://doi.org/10.3390/scipharm87010006.